Austin has over a decade of finance and accounting experience in a variety of roles, and eight years of experience within the medical diagnostics industry. He joined Sera in July 2017, most recently serving as Sera’s Vice President of Finance and Corporate Controller prior to his appointment as CFO. In his time with the Company, Austin has been responsible for numerous process and internal control improvements, and other vital financial responsibilities. In addition to overseeing the financial reporting, audit management, technical accounting, financial risk, cash management, and planning for the Company, Austin played a key role in the Company’s initial public offering in 2021. Prior to joining the Company, Austin worked for Myriad Genetics in the Finance department, and for Ernst & Young LLP as an assurance professional serving a variety of public and private clients, including Sera. Austin holds a Master of Accounting from the University of Utah and is an active Certified Public Accountant licensed in the State of Utah.